Critical Care & Emergencies (all articles)
Review: Implementing an early rule-out pathway for acute myocardial infarction in clinical practice.
29 Sep, 2021 | 10:00h | UTCImplementing an early rule-out pathway for acute myocardial infarction in clinical practice – Heart
Review: Life-threatening skin conditions presenting to critical care.
28 Sep, 2021 | 08:57h | UTCLife-threatening skin conditions presenting to critical care – BJA Education
Podcast: Neutropenic Fever.
28 Sep, 2021 | 08:52h | UTC#288 LIVE! Neutropenic Fever featuring Dr. Susan Seo – The Curbsiders
Updated WHO Living Guideline: Therapeutics and COVID-19.
26 Sep, 2021 | 22:16h | UTCTherapeutics and COVID-19: living guideline – World Health Organization
WHO Statement: On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19
See also:
WHO recommends antibody treatment for COVID patients at high risk of hospital admission.
Commentary: WHO adds new recommendation for COVID-19 monoclonal antibody combo – CIDRAP
Evaluating the Cost-effectiveness of Prehospital Plasma Transfusion in Unstable Trauma Patients: A Secondary Analysis of the PAMPer Trial.
26 Sep, 2021 | 21:54h | UTCEvaluating the Cost-effectiveness of Prehospital Plasma Transfusion in Unstable Trauma Patients: A Secondary Analysis of the PAMPer Trial – JAMA Surgery (free for a limited period)
Commentaries:
CHEERS to You on a Well-done Cost-effectiveness Analysis of Prehospital Plasma for Helicopter Resuscitation of Patients With Traumatic Shock – JAMA Surgery (free for a limited period)
Prehospital Plasma: A Cheap, Effective Way to Save Trauma Patients’ Lives? – BreakingMed
Commentary on Twitter
A cost-effectiveness analysis of the pragmatic, randomized, multicenter PAMPer trial reveals thawed plasma administration for trauma patients in hemorrhagic shock during air medical transport is life-saving and cost-effective https://t.co/WDCoJctZox
— JAMA Surgery (@JAMASurgery) September 24, 2021
[Preprint] PRINCIPLE RCT: Colchicine does not improve time to recovery in outpatients with Covid-19 at higher risk of complications.
24 Sep, 2021 | 10:13h | UTC
Commentary on Twitter
While COLCORONA trial found limited evidence that colchicine may reduce COVID-19 related hospitalisation/death
🆕💥💥@TrialPrinciple preprint
Colchicine did NOT improve time to recovery in people at higher risk of complications w COVID-19 in the communityhttps://t.co/2sUoeD7sGV pic.twitter.com/fi2THbxewW— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 23, 2021
WHO recommends antibody treatment for COVID patients at high risk of hospital admission.
24 Sep, 2021 | 10:11h | UTCOriginal article and infographic: A living WHO guideline on drugs for covid-19 – The BMJ
Review: Focused management of patients with severe acute brain injury and ARDS.
24 Sep, 2021 | 08:52h | UTCFocused Management of Patients with Severe Acute Brain Injury and ARDS – CHEST
Systematic review: Clinical characteristics of multisystem inflammatory syndrome in adults.
23 Sep, 2021 | 10:12h | UTC
Commentary on Twitter
Multisystem inflammatory syndrome has been reported in adults worldwide but may be hard to distinguish from acute biphasic #COVID19 and postacute sequelae of COVID-19. More research is needed to understand this emerging clinical entity. https://t.co/OnerzsZKVB
— JAMA Network Open (@JAMANetworkOpen) September 22, 2021
Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition.
23 Sep, 2021 | 09:51h | UTC
Phenotypes and subphenotypes of delirium: a review of current categorizations and suggestions for progression.
23 Sep, 2021 | 09:54h | UTC
Consensus Conference: Critically ill cancer patient’s resuscitation.
22 Sep, 2021 | 10:16h | UTC
Commentary on Twitter
Critical care for cancer pts: 🇧🇪/🇫🇷 consensus conference
1⃣Triage for #ICU admission
2⃣Ventilatory support & #ECLS
3⃣RRT
4⃣Hemodynamic support
5⃣Benefit of CPR?
6⃣Intensive monitoring
7⃣Specific considerations
8⃣Blood products
9⃣Training for ICU doctorshttps://t.co/bqPR1v0Um1 pic.twitter.com/GNvooA85IM— Intensive Care Medicine (@yourICM) September 21, 2021
Essential Emergency and Critical Care: A consensus among global clinical experts.
22 Sep, 2021 | 10:07h | UTCEssential Emergency and Critical Care: a consensus among global clinical experts – BMJ Global Health
News releases:
40 steps to reduce deaths from critical illness – London School of Hygiene & Tropical Medicine
40 simple steps to reduce deaths from critical illness – Karolisnka Institutet
Commentary on Twitter
Blueprint for hospitals on how to reduce preventable deaths due to critical illness has been set out 🏥
New study in @GlobalHealthBMJ outlines 4⃣0⃣ steps to prioritise essential care & improve #pandemic preparedness.
👉 https://t.co/hpVMXUZ1vb #COVID19 #PublicHealth pic.twitter.com/5BBZDCVkFM
— London School of Hygiene & Tropical Medicine (@LSHTM) September 21, 2021
RCT: Probiotics do not reduce the incidence of ventilator-associated pneumonia in critically ill patients.
22 Sep, 2021 | 10:03h | UTCEffect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial – JAMA (free for a limited period)
Commentary: Probiotic Flops for Ventilator-Associated Pneumonia Prevention – MedPage Today (free registration required)
Palliative and End-of-Life Care: Prioritizing Compassion Within the ICU and Beyond.
22 Sep, 2021 | 09:57h | UTC
Cluster RCT: Procalcitonin point-of-care testing may reduce antibiotic prescription for patients with suspected lower respiratory tract infection in primary care.
22 Sep, 2021 | 10:01h | UTC
Cluster RCT: Implementing C reactive protein point-of-care testing in nursing homes may reduce antibiotic prescribing for suspected lower respiratory tract infections.
22 Sep, 2021 | 10:02h | UTC
The Evolution of Hemodynamic Monitoring and Support.
22 Sep, 2021 | 09:58h | UTCHemodynamic Monitoring and Support – Critical Care Medicine
Commentary on Twitter
Evolution of hemodynamic monitoring for #CriticalCare#TBT for #SCCM50Years #SCCMSoMe from @jlvincen @BerndSaugel in @CritCareMedhttps://t.co/T4lr1ltGoW pic.twitter.com/mOQ2LhdXLx
— Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FAAN, FCCM (@SCCMPresident) July 22, 2021
M-A: Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19 – According to this analysis, standard-dose prophylactic anticoagulation should be the standard of care for hospitalized patients with COVID-19 who do not have an indication for therapeutic anticoagulation, irrespective of disease severity.
21 Sep, 2021 | 09:54h | UTC
Commentary on Twitter (thread – click for more)
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with #COVID-19: A systematic review and meta-analysis of randomized controlled trials https://t.co/Gkdfp9vn75 @ESC_Journals @escardio @ESCardioNews #COVID19
— Luis Ortega Paz (@Ortega_Paz) September 15, 2021
Review: Transfusion-related acute lung injury in the perioperative patient.
21 Sep, 2021 | 08:56h | UTCTransfusion-related Acute Lung Injury in the Perioperative Patient – Anesthesiology
RCT: Rivaroxaban does not have an impact on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
17 Sep, 2021 | 10:19h | UTC
WSES-AAST Guidelines: Anorectal Emergencies.
17 Sep, 2021 | 10:06h | UTCAnorectal emergencies: WSES-AAST guidelines – World Journal of Emergency Surgery
Guideline: Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome.
17 Sep, 2021 | 10:07h | UTC
ACSM Expert Consensus Statement on Exertional Heat Illness: Recognition, Management, and Return to Activity.
17 Sep, 2021 | 10:03h | UTCRelated: Guidelines for the Prevention and Treatment of Heat Illness
The use of head helmets to deliver noninvasive ventilatory support: a comprehensive review of technical aspects and clinical findings.
17 Sep, 2021 | 09:57h | UTC